Livezey, Jeffrey http://orcid.org/0000-0001-9748-095X
Twomey, Patrick
Morrison, Meshell
Cicatelli, Susan
Duncan, Elizabeth H.
Hamer, Melinda
Lee, Christine
Hutter, Jack
Mills, Kristin
DeLuca, Jesse
Poon, Lucas
Selig, Daniel
Vuong, Chau
Sousa, Jason
Oliver, Thomas
Bennett, Jason
Moon, James E.
Sikaffy, April
Sedegah, Martha
Tosh, Donna
Kreishman-Deitrick, Mara
Waterman, Paige
Clinical trials referenced in this document:
Documents that mention this clinical trial
An open label study of the safety and efficacy of a single dose of weekly chloroquine and azithromycin administered for malaria prophylaxis in healthy adults challenged with 7G8 chloroquine-resistant Plasmodium falciparum in a controlled human malaria infection model
https://doi.org/10.1186/s12936-020-03409-z
Funding for this research was provided by:
Congressionally Directed Medical Research Programs (CDMRPL-16-0-PR141035A)
Article History
Received: 24 June 2020
Accepted: 4 September 2020
First Online: 16 September 2020
Ethics approval and consent to participate
: The study was performed according to the Declaration of Helsinki and International Conference on Harmonization Good Clinical Practice Guidelines. The clinical protocol was reviewed and approved by the WRAIR and Uniformed Services University of the Health Services Institutional Review Boards. The study was also conducted in accordance with US FDA regulations. All participants provided written informed consent prior to participating in any study activities.
: Not applicable.
: The authors declare that they have no competing interests.